Novartis, GlaxoSmithKline enter pipeline boosting deals
Novartis and GlaxoSmithKline announced separate deals with smaller biotech firms to ramp up their respective product pipelines.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.